The global medical specialty bags market size was estimated at USD 6.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. This growth is mainly due to the increase in the elderly population and the rising prevalence of acute diseases such as urinary bladder cancer and other urinary bladder-related disorders. Medical specialty bags are used to store and deliver various fluids, drugs, and nutrients to patients while maintaining a sterile and hazard-free environment around the infected site. Blood storage, bile collection, gastrointestinal feeding, and sterile packaging are some of the key applications of medical bags. Medical bags can be used to control bowel incontinence and bile leakage.
According to the World Health Organisation (WHO), 120 million units of blood are donated annually globally, and these blood storage and transfusion activities require blood bags. Rubber, latex, and plastic are used to make blood, urinary, ostomy, intravenous (IV), and enteral bags with different capacities and shapes.
According to the National Institute of Health (NIH), there will be 142.66 million people aged 50 and older in 2050 who have at least one chronic disease, up from 71.52 million in 2020, a 99.5% increase. Simultaneously, it is anticipated that the number of people with multimorbidity will rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. This is a major upward trend in the market for medical accessories such as medical specialty bags.
Ostomy collection pouches are helpful on account of the prevalence of uncontrollable maladies, and it is anticipated to fuel the market demand owing to the rising old age populace. Uniform compensation policies, easy availability of products, and cost-effectiveness make the product affordable, lucrative, and flexible for consumers.
Government agencies are essential for the expansion of the product market because they support rising demand by investing in health infrastructure, creating better reimbursement plans, raising public awareness, establishing competitive prices, and promoting research and development. The market is anticipated to grow due to rising concerns for health and hygiene, changes in technological trends, and improvements in medical standards and facilities.
The COVID-19 pandemic impacted the market negatively initially, as many non-life-threatening surgeries were postponed, leading to a decrease in the demand for these bags. Later, there was an increase in custom specialty bags for collecting various bodily samples for COVID-19 contraction testing. Hence, the overall of impact COVID-19 on the market was positive.
Based on products, the market is segmented into urinary collection, blood, anesthesia breathing, bile collection, ostomy collection, sterile packaging, enteral feeding, resuscitation, continuous ambulatory peritoneal dialysis (CAPD), intravenous fluid, cadaver, ice, and enema. Ostomy collection bags are further segmented into single-use and multiple-use. Resuscitation bags are further divided into reusable and disposable. Besides, intravenous fluid bags are further sub-categorized into non-PVC material and PVC material-based.
In 2022, the ostomy collection bags segment accounted for the largest market share of more than 30.0% as they are used to collect solid body excreta as well as gaseous body excreta through a stoma in the abdomen, without passing through the rectum. The rising number of ostomy surgical procedures, especially among the geriatric population, are likely to contribute to the market growth.
On the other hand, the bile collection bags segment is projected to grow at a CAGR of 6.5% over the forecast period from 2023 to 2030. Bile collection bags are used to collect and store bile from the liver and are used to relieve inflammation in the gall bladder, to diagnose and treat ailments related to the biliary system, and for surgical removal of the gall bladder or part of the bile duct.
In 2022, North America dominated the market with a revenue share of more than 45.0% and is expected to hold the leading position throughout the forecast period. North America has a strong and well-established healthcare infrastructure as well as a better technology adoption rate, contributing to market growth. Pharmaceutical players in this region are continuously investing in the development of medical specialty bags. According to the Centers for Medicare and Medicaid Services (CMS), National Health Expenditure (NHE) increased by 2.7% to USD 4.3 trillion in 2021 or USD 12,914 per person, and it represented 18.3% of the GDP. Spending on Medicare increased by 8.4% to USD 900.8 billion in 2021 or 21% of all NHE.
Asia Pacific is expected to witness the fastest CAGR of 6.4% during the forecast period. The increasing focus on investing in the healthcare sector to support the large population and its rapid growth, as well as facilitating the speedy development of the region are the key growth contributors. For instance, in India, the estimated expenditure of the Department of Health and Family Welfare is USD 10.42 billion for the year 2023-2024, which is an increase of 13% from the year 2022-2023.
Some of the key market players are undertaking a variety of crucial business strategies, including product launches, approvals, strategic acquisitions, and innovations to maintain and expand their global outreach. For instance, Hollister Incorporated announced the expansion of operations in Lithuania in February 2023 by investing USD 25 million in cutting-edge manufacturing technologies.
Many technologically advanced products are being introduced by key players, increasing their reliability and efficiency. As per a study in March 2023, The Coloplast Group reported an improvement in bladder emptying with Luja, in 90% of catheterizations. Luja, which has more than 80 micro-holes, completely empties the bladder in a single free flow, compared to 52% for the 2-eyelet VaPro catheter from Hollister Incorporated.
Amcor introduced an enhanced-stock product program for the healthcare industry in October 2021. The program enables customers to order from a variety of market-recognized DuPont Tyvek bags and breather bag header bags, both of which come with low minimum order quantities. These materials are ideal for use in Class I, II, and III equipment and products that call for high-value cleanroom production and have strong puncture and resistance to abrasion. They are also great for applications that must compete on price.
The healthcare infrastructure growth in emerging economies such as India, China, Mexico, and Brazil is gaining momentum, thereby proposing lucrative prospects for the leading vendors of the industry. The soaring demand for superior technology and sophisticated tools, together with medical specialty bags that support various medical procedures during or after treatments is expected to open new avenues for competing participants. Some prominent players in the global medical specialty bags market include:
B Braun Medical
C.R. Bard Inc.
Kawasumi Laboratories Inc.
Fresenius Medical Care AG & Co.
Baxter International Inc.
Westfield Medical Ltd.
Market size value in 2023
USD 6.67 billion
Revenue forecast in 2030
USD 9.38 billion
CAGR of 5.0% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion, and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, trends
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Hollister Incorporated; B Braun Medical; Terumo Corporation; Coloplast A/S; Pall Corporation; C.R. Bard Inc.; Kawasumi Laboratories Inc.; Fresenius Medical Care AG & Co.; Baxter International Inc.; Convatec Inc.; Macopharma; Westfield Medical Ltd.
Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical specialty bags market report based on product, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Anaesthesia Breathing Bags
Urinary Collection Bags
Bile Collection Bags
Sterile Packaging Bags
Ostomy Collection Bags
Enteral Feeding Bags
Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
Intravenous Fluid Bags
PVC Material-based Fluid Bags
Non- PVC Material-based Fluid Bags
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East and Africa
b. The global medical specialty bags market size was estimated at USD 6.4 billion in 2022 and is expected to reach USD 6.67 billion in 2023.
b. The global medical specialty bags market is expected to grow at a compound annual growth rate of 5.0% from 2023 to 2030 to reach USD 9.38 billion by 2030.
b. North America dominated the medical specialty bags market with a share of 45.9% in 2022. This is attributable to rapid growth in consciousness among people and progress in emerging economies due to technological trends.
b. Some key players operating in the medical specialty bags market include Terumo Corporation Hollister Incorporated, Coloplast A/S, B Braun Medical, Pall Corporation, C.R. Bard Inc., Kawasumi Laboratories Inc, Terumo Corporation, Baxter International Inc., Westfield Medical Ltd., Maco Pharma, Convatec Inc., and Fresenius Medical Care AG & Co
b. Key factors that are driving the market growth include growing need for customer focused products/services, improving patient awareness and growing geriatric population
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."